Prof. Tara Gomes and Associate Prof. Mina Tadrous have received a 2026 @utoronto.ca President’s Impact Award for their leadership through @odprn.bsky.social.
We are proud to celebrate this recognition: www.utoronto.ca/celebrates/u...
New update to our Opioid Indicator Tool!
This update includes data up to Q3 2025 and incorporates merged PHU data to reflect the 2025 PHU mergers.
Learn more at odprn.ca/ontario-opio...
We’re incredibly proud and grateful to be named a 2026 Laureate of the President’s Impact Award.
This recognition reflects the collective efforts of our team, partners, and collaborators in shaping policies that impact millions of Canadians.
Thank you to everyone who has been part of this journey!
March data on #opioid-related deaths in #Ontario from the OCC is now available.
🚨There were 208 suspect drug-related deaths reported in March 2026 in Ontario.
Data available for download at odprn.ca/occ-opioid-a...
Upcoming webinar with CATIE and CanHepC will explore how recent changes are affecting harm reduction services and what can be done to support this public health response.
📅 April 20, 2026
🕐 1 to 2:30 p.m. EDT
Register at www.catie.ca/harm-reducti...
New ODPRN study found early methadone dose titration was associated with improved treatment retention and lower hazard of opioid toxicity.
Learn more at odprn.ca/research/pub...
New ODPRN study finds a 3-fold increased risk of opioid toxicity when CYP3A4-inhibiting macrolides (clarithromycin, erythromycin) are used with opioids.
Learn more at odprn.ca/research/pub...
@icesontario.bsky.social @unityhealthto.bsky.social
NEW ODPRN study found increased uptake of safer opioid supply (SOS) among First Nations Peoples in Ontario, with the highest rates among those aged 25 - 44 and those living outside of First Nations communities and in urban areas.
Learn more at
odprn.ca/research/pub...
Pharmacist and Drug Policy Researcher Mina Tadrous talks about the sharp increase of adult prescriptions for ADHD since 2020.
www.ctvnews.ca/video/2026/0...
New ODPRN study found RAPID uptake of Flash Glucose Monitoring system among both immigrants and long-term residents in the first few months of this product becoming publicly funded.
odprn.ca/research/pub...
NEW ODPRN study found that prescriptions for stimulant medications for adults in Ontario increased during COVID-19. People starting these medications were more likely to be women and adults aged 25–34, and less likely to have their prescriptions initiated by psychiatrists. odprn.ca/research/pub...
New ODPRN study shows opioid agonist therapy use in Canada increased between 2018 and 2022, especially in rural areas & in provinces experiencing rising opioid-related harms. We also saw differences in access across provinces & a growing shift toward buprenorphine treatment.
odprn.ca/research/pub...
New data from Toronto's Drug Checking Service shows a dangerous shift in the drug supply:
⚠️ 40%+ of fentanyl samples now contain benzos (highest since 2024).
⚠️ Dual Risk: Almost all also contain the tranquilizer medetomidine.
Details available at drugchecking.community
📣Upcoming Webinar Alert!
Making Research Matter: Approaches to Strengthen Connections between Research, Policy, and Community
📅 Tuesday, April 7 2026 | 1 - 2:30pm EST
🔗 Register: www.nihs.pharmacy.utoronto.ca/events-news/...
Hosted by the Network for Improving Health Systems (NIHS) & the ODPRN
Understanding substance use trends by region, demographics and time helps direct resources for prevention, treatment and more. Our new #CSUCH Prevalence Chart shows how many people use different substances across Canada by age, sex and year. Check it out: https://csuch.ca
New in #CPJ:
A framework for pharmacy-sensitive quality indicators (PSQIs). This framework can be used to measure and demonstrate the real impact pharmacists have on patient outcomes. Learn more at
utppublishing.com/doi/10.3138/...
January data on #opioid-related deaths in #Ontario from the OCC is now available.
🚨There were 224 suspect drug-related deaths reported in January 2026 in Ontario.
Data available for download at odprn.ca/occ-opioid-a...
Today is the UN International Day of Women and Girls in Science, so we’re putting the spotlight on @melodyglenn.bsky.social and Dr. Marie Nyswander! @filtermag.bsky.social
Today, on the International Day of Women and Girls in Science, the ODPRN recognizes and celebrates the incredible contributions of women on our team and across the research and scientific community. 👩🔬
www.womeninscienceday.org
#WomenInScience #IDWGS #HealthResearch #EvidenceInformed #ODPRN
The flu isn’t “just flu.” New Ontario research links flu activity to higher risk of invasive pneumococcal disease, and shows RSV’s link appears strongest when flu is also circulating. Another reminder why prevention and vaccination is important. vist.ly/4r8ri
New ODPRN study finds Ontario’s biosimilar policy achieved high biosimilar uptake and substantial cost savings, with most savings attributed to non-insulin biosimilars.
Learn more at odprn.ca/research/pub...
STARTING TODAY AT 11:30!
Join this important conversation and register at ca01web.zoom.us/webinar/regi...
Today is Bell Let’s Talk Day — a reminder of the importance of talking openly about mental health.
Our Depression Town Hall showed how sharing lived experience helps ensure that real voices inform research and policy.
You can hear their stories at odprn.ca/town-halls/d...
#BellLetsTalk
Congratulations to Dr. Tara Gomes for being awarded the 2025 Peggy Leatt Knowledge & Impact Award! See all the Unity Health members who have been recognized this month at: unityhealth.to/2025/11/nove...
@zoedodd.bsky.social
Only 1 week away!
Register at ca01web.zoom.us/webinar/regi...
NEW ODPRN study found that across Canada, there was significant growth in fentanyl-containing drug seizures with multiple substances detected – most notably benzodiazepines, xylazine and potent fentanyl analogues within a single sample.
Learn more at odprn.ca/research/pub...
@cihica.bsky.social
@unityhealthto.bsky.social
@icesontario.bsky.social
NEW ODPRN study shows the increasing role of the potent, unregulated drug supply in opioid toxicities across Canada and explores how prescription opioid–related harms vary by population group, location, and opioid use.
odprn.ca/research/pub...
